On Invalid Date, Bluejay Diagnostics (NASDAQ: BJDX) reported Q3 2023 earnings per share (EPS) of -$2.08, up 29.25% year over year. Total Bluejay Diagnostics earnings for the quarter were -$2.30 million. In the same quarter last year, Bluejay Diagnostics's earnings per share (EPS) was -$2.94.
As of Q1 2024, Bluejay Diagnostics's earnings has grown year over year. Bluejay Diagnostics's earnings in the past year totalled -$10.04 million.
What was BJDX's revenue last quarter?
On Invalid Date, Bluejay Diagnostics (NASDAQ: BJDX) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Bluejay Diagnostics's revenue was $0.00.
What was BJDX's revenue growth in the past year?
As of Q1 2024, Bluejay Diagnostics's revenue has grown -100% year over year. This is 109.1 percentage points lower than the US Medical Devices industry revenue growth rate of 9.1%. Bluejay Diagnostics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.